Prosecution Insights
Last updated: November 04, 2026

Ckp Therapeutics Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Ckp Therapeutics Inc. maintains a patent portfolio within the Biotechnology & Pharmaceuticals technology area. The data indicates 1 pending office action currently active. KIM, SEONG JONG is the busiest examiner and is responsible for the pending office action.

The prosecution environment is centralized, involving 1 distinct examiner and a distinct art unit. Because KIM, SEONG JONG manages the workload, the company's success in this matter depends on addressing the specific concerns of this examiner. This structure simplifies the management of the portfolio by focusing on a point of contact at the patent office.

The presence of a distinct art unit suggests that the pending application falls within a specific technical niche. Practitioners should focus on the examiner's previous rulings and preferences to navigate the prosecution process. Since there is a pending office action, the resolution of this case will be a primary driver of the portfolio's immediate growth and success.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KIM, SEONG JONG 1 20.0% +0.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18386985 COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER KIM, SEONG JONG —

Top Art Units

Art UnitApps
1621 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18386985 COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER KIM, SEONG JONG 1621 §112 Non-Final OA — Pending Nov 03, 2023

Managing Ckp Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Ckp Therapeutics Inc. have?

Ckp Therapeutics Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Ckp Therapeutics Inc. applications?

Seong Jong Kim has the most, with 1 of Ckp Therapeutics Inc.'s pending office actions.

What technology area are Ckp Therapeutics Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month